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Participant recruitment is an important process in successful conduct of randomized controlled
trials. To facilitate enrollment into a National Institutes of Healthesponsored clinical trial
involving patients with chronic obstructive pulmonary disease (COPD), we developed and
prospectively validated an automated electronic screening tool based on boolean free-text
search of admission notes in electronic medical records. During a 2-week validation period,
all patients admitted to prespecified general medical services were screened for eligibility
by both the electronic screening tool and a COPD nurse. Group discussion was the gold stan-
dard for confirmation of true-positive results. Compared with the gold standard, electronic
screening yielded 100% sensitivity, 92% specificity, 100% negative predictive value, and 72%
positive predictive value. Compared with traditional manual screening, electronic screening
demonstrated time-saving potential of 76%. Thus, the electronic screening tool accurately
identifies potential study subjects and improves efficiency of patient accrual for a clinical trial
on COPD. This method may be expanded into other institutional and clinical settings.
ª 2011 Elsevier Ltd. All rights reserved.mming interface; CI, confidence interval; COPD, chronic obstructive pulmonary disease; DDQB, data
ctronic medical record; IQR, interquartile range; MCLSS, mayo clinic life sciences system; METRIC,
ranslational research in intensive care; NIH, National Institutes of Health; NLP, natural language
alue; PPV, positive predictive value.
ormed at Mayo Clinic, Rochester, MN, USA.
1th Street, Cleveland , OH 44113, USA. Tel.: þ1 507 261 1210.
ail.com (C.N. Schmickl), benzo.roberto@mayo.edu (R.P. Benzo).
1 Elsevier Ltd. All rights reserved.
1502 C.N. Schmickl et al.Introduction the E-screening tool on sensitivity rather than specificity.The efficient recruitment of adequate numbers of partici-
pants is one of the most important processes in the
successful conduct of randomized controlled trials. Trials in
all medical specialties face problems with recruiting
patients. Recruitment success is determined by 3 factors:
the identification of eligible patients, the recruiters’e and
the patients’ attitude towards participation. For latter 2
factors, various authors have discussed issues and strate-
gies to overcome them, although approaching and enrolling
patients did not progress markedly in the past decade.1e4
However, identification of eligible patients has improved
considerably, especially with use of electronic medical
records (EMRs).5e10 These systems generally either notify
health care providers at the point of care (Clinical Trial
Alerts) or create patient lists on a regular basis (electronic
screening or E-screening); most are based on a search for
discrete data points, for instance, age or laboratory results.
To our knowledge, only 1 small study reported the valida-
tion of an E-screening device for study recruitment that
applied a free-text search,7 and no evaluation of
a computerized screening system targeting patients
admitted for an exacerbation of chronic obstructive
pulmonary disease (COPD) exists.Background
Our study was performed at a tertiary care center with
integrated EMR systems that were introduced in 1995,
providing the base for efficient, coordinated, safe, and
high-quality care. All institution-wideeentered data are
stored and thus accessible in the Mayo Clinic Life Sciences
System (MCLSS) warehouse. Details of its content are shown
in Appendix E1 available as an online data supplement. The
richness of available electronic data has encouraged the
creation of several surveillance tools currently being used
in clinical care. The Division of Pulmonary and Critical Care
Medicine at the study institution uses an E-screening tool to
identify patients with acute lung injury to facilitate early
treatment of these patients11; another clinical trial alert is
used to notify physicians via pager if their patients
on ventilators are exposed to unnecessarily high tidal
volumes.12 From these experiences, we hypothesized that
E-screening for the identification of potential study
subjects is feasible and potentially useful for clinical trials
recruitment.Design objectives
The aim of our study was to test the accuracy and efficacy
of a time-sensitive free-text search to identify patients
admitted for COPD exacerbation vs a manual search of the
records to facilitate recruitment for an National Institute of
Health (NIH)efunded study that will test multicomponent
intervention to decrease COPD-related hospitalizations.
Since our intention was to apply E-screening in a pre-
screeningefashion, that is helping the nurse study coordi-
nator with the prospective identification of potential study
participants for this NIH-trial, we focused in the design ofSecondary objective was to reduce the workload (ie, the
time spent screening) of the study coordinator as much as
possible by minimizing the portion of patients found false
positively “eligible” by E-screening (ie, maximizing positive
predictive value).
System description
Design and infrastructure of the E-screening tool
E-screening is mainly driven by the electronic free-text
search engine, which was designed to execute the algo-
rithm against the admission notes of the clinical records in
MCLSS, generate daily reports containing the list of
potentially eligible patients, and send the report to the
study coordinator. The E-screening tool was built by using
our Multidisciplinary Epidemiology and Translational
Research in Intensive Care (METRIC) common business
framework and Data Definition and Query Builder (DDQB)
application programming interface (API). It is coded in Java
and can run on any platform.
The application is scheduled to run automatically every
morning at 6 AM (see Figure E1 available as an online data
supplement).
The DDQB system interface allows programmatic appli-
cation of search criteria to the MCLSS database. To use the
DDQB API, we have overcome the following challenges:
 Access challenge: MCLSS provides a graphic user inter-
face query tool called DDQB to end users, which
provides access to the database. DDQB has been well
configured, but our goal was to automate the report.
Therefore, we could not take advantage of this existing
connection configuration. We had to create a custom-
ized DDQB client to access DDQB system interface.
 Integration challenge: DDQB accepts only special
DDQB-type request objects, which are not in a standard
SQL format. Thus, we had to use DDQB query objects to
set up our report query criteria. Similarly, the retrieved
DDQB result sets are not in standard SQL format, forcing
us to translate the results to generate the daily reports.
The METRIC framework is an automating framework,
which is designed and developed by METRIC development
team to run any specified algorithmddefined in an XML
format filedand ICU common business objects handle the
database connection, SQL, report, schedule, and mail
processing.
The E-screening tool queries the free-text sections in
the admission notes of the EMR for any of the following
terms: COPD, COPD exacerbation, respiratory failure,
hypercapnia, emphysema, chronic bronchitis, home O2.
Validation of the E-screening tool
Fourteen general medical in-hospital services anticipated
to have high numbers of eligible patients were screened by
both electronic free-text search and a registered nurse
specialized in COPD care during a 2-week period, January
2e15, 2010. In the morning of each weekday the nurse
Figure 1 Workflow of E-screening tool during validation
period.
E-screening for clinical trial subjects 1503manually searched through all medical records of the pre-
defined medical services for patients admitted in the
previous 24 h. Among those, potential trial candidates were
identified taking into consideration all information avail-
able in the EMR and applying all inclusion and exclusion
criteria of the NIH-funded study (Table 1). In the end of
each screening session the total number of patient records
reviewed and the time to complete this task were docu-
mented. During manual screening the nurse was blinded to
the E-screening results.
The gold standard was defined as manual screening plus
a group discussion (to include all true-positive results) that
involved all investigators. The results of both the E-screening
and themanual search alonewere compared against the gold
standard (manual search plus group consensus of true-
positive results). Sensitivity, specificity, and positive
and negative predictive values were then calculated.
Institutional review board approved the use of medical
records for research and waived the requirement for
written informed consent.
Status & report
The workflow of the E-screening tool used for validation is
shown in Fig. 1. One hundred two patients were newly
admitted during the validation period. In total, 25 patients
were classified as eligible by E-screening vs 20 by the nurse
study coordinator. Finally, the group consensus identified
18 patients as eligible for the trial (Fig. 2).
The reasons for misclassifications made by E-screening
(7) were mainly due to mentioning of COPD as a secondary
or tertiary condition in the admission note that was not
related to the current admission. The nurse study coordi-
nator identified 2 patients false positively as eligible
because in the body of notes (not searched through by
E-screening) there was some discussion about COPD as
a differential diagnosis. Group consensuseincluding expe-
rienced physicianseidentified these cases as clear Asthma
exacerbation or Heart Failure manifestations, respectivelyTable 1 Eligibility criteria of the NIH-funded trial on
COPD in detail.
Inclusion Criteria
Age 40 years old
Diagnosis of GOLD stage II, III, or IV COPD documented
by pulmonary function testing
Current or previous smoker with at least 10 pack-years
of cigarette smoking
Hospitalized for an exacerbation of COPD
Exclusion Criteria
Patients with a high likelihood of being lost to follow-up
or contact
Female patients who are currently pregnant
Patents with characteristics that can confound the
analysis of the primary outcome
Patients with an inability to provide good data
or follow commands
Patients with an inability to walk when their
COPD is stable(details in Table E1 available as an online data
supplement).
Table 2 displays the results of each E-screening and
manual chart review in comparison with the gold standard.
Both screening methods had similar performance (Table 3).
No method missed eligible patients as per gold standard
(100% sensitivity, respectively). E-screening had a slightly
higher rate of false positive events than manual review,
which resulted in a lower specificity and positive predictive
value. In total, E-screening discarded 76% (77/102) of all
study subjects correctly as ineligible.
Each day the nurse study coordinator reviewed a median
of 106 records (interquartile range [IQR], 103e110) and
spent a median time of 52 min (IQR, 42e59 min) on the
manual screening.
Discussion
Our results suggest that E-screening based on free-text
search is an efficient and accurate method to capture
potential candidates for this NIH-funded trial on COPD.
While ensuring maximum identification of eligible patients
Figure 2 E-screening and manual review in comparison to gold standard.
1504 C.N. Schmickl et al.it also minimizes the screening workload of the nurse study
coordinator: During the 2-week validation period,
E-screening did not miss any eligible patient and classified
76% of all newly admitted patients correctly as ineligible
(100% negative predictive value). Thus E-screening method
allows focusing the manual review on only the 25% of
patients with a high chance of being eligible (72% positive
predictive value) instead of screening all newly admitted
patients. In our validation scenario this would translate into
a time-saving of about 40 min per day (76%).
Patient recruitment is believed to be one of the greatest
barriers in the conduct of randomized controlled trials.
Clinical trials from all disciplines face similar difficulties in
recruiting patients. Before the availability of EMR, recruit-
ment strategies related to in-hospital patients were mainly
based on referrals from health workers, including nurses and
physicians. Thus, the efficiency and accuracy were largely
dependent on the active attitudes of these related health
workers. In the past 10 years, since the introduction of the
EMR, a number of automated electronic recruitment strat-
egies have been successfully developed and validated.5,7e10
Targeting patients with diabetes mellitus, Thadani et al
recently reported similar performance with use of their
electronic screening device, which is based on a query of
discrete data points (eg, laboratory tests, age).10 They sug-
gested that natural language processing (NLP) might be
a future direction to improve automated screening for
recruitment purposes. Although we did not comply with the
strict rules of an NLP method, we demonstrated that even
a simple free-text search can achieve comparable success
rates, with the advantages of being a faster and less expen-
sive development process. Weiner et al also demonstrated






Manual Review Eligible 18
Manual Review Ineligible 0
Total 18patients with sickle cell disease among a pediatric pop-
ulation, using a small, emergency department registry as
data source.7 By comparison, we ran our query against
a large-scale clinical warehouse.
The best features of electronic surveillance are its high
efficiency and its ability to substantially reduce the time
spent screening. The time freed during screening can then be
used for amore thoroughdetermination of thefinal eligibility
status and possibly also bedside discussion with potential
participants to not only avoid the recruitment of non-
qualifying patients, but also potentially increase the chances
of enrolling eligible ones. As shown in our study, even highly
specializedmanual screening (a review performed by a nurse
who specializes in COPD) does not provide 100% accuracy in
determining eligibility. One possible explanation may be the
trade-off between sensitivity and specificity, which influ-
ences the accuracy of the decision process as in any other
test. Yet,more critical for the overall accuracy of themanual
review is probably the amount of information that needs to
beprocessed in the timeavailable. In thevalidation scenario,
the nurse doing the manual search first had to screen
a median of 106 patient charts daily for new admissions,
before determining eligibility in a later second step.
Up-to-date E-screening devices cannot completely
replace manual screening but serve as an initial filter to
identify potentially eligible patients. The combination of
electronic and manual screening may substantially decrease
theworkload of study coordinators. In our study, to identify 1
potential study subject the study coordinator had to review
approximately 5 patient records (18% prevalence) vs 1.5
charts after E-screening (72% positive predictive value).
The performance of the E-screening tool could also be









Table 3 Performance of both screening methods when




review % (95% CI)
Sensitivity 100 (78e100) 100 (78e100)
Specificity 92 (83e96) 98 (91e100)
PPV 72 (50e87) 90 (67e98)
NPV 100 (94e100) 100 (94e100)
Abbreviations: CI Z confidence interval, PPV Z positive
predictive value, NPV Z negative predictive value.
E-screening for clinical trial subjects 1505other purposes. For example, if the target population were
patients with rather rare conditions, the automatic
screening tool could be tuned to be more sensitive and less
specific by modifying and expanding the keywords of the
query to ensuremaximal sample size. Depending on the level
of representation and ambiguity of terms commonly used to
describe the targeted condition, the performance of such
modified E-screening tools may differ. In some cases, more
elaborate techniques likeNLPmaybewarranted tomaximize
the overall accuracy. From our experiences, however, free-
text searchesdalone or in combination with queries for
certain laboratory valuesdcan be a powerful screening
method. This method has been used clinically in our institu-
tion to identify patients with acute lung injury or to alert
physicians about inappropriate mechanical ventilation.11,12
The E-screening tool described in this paper could also be
used to identify COPDpatients at high risk of readmission and
mortality for other studies or quality improvement
projects.13 Modified, it may also identify pneumonia or heart
failure patients who need special attention and in whom
a special quality-of-care protocol needs to be instituted.
Overall, the flexibility of E-screening based on free-text
searching provides timely identification of various target
populations.Limitations
Our results are limited by the fact that we evaluated the
screening tool only in selected inpatient services (i.e., those
with the highest likelihood of having the target subjects) for
a relatively short time. However, during the 2-week period,
a total of1901patientswereadmitted to thehospital. Itwould
not have been feasible to screen all of them manually.
Nevertheless, by selecting general medical services with high
potential for eligible candidates, we were able to get a good
estimate of the overall performance of the E-screening tool.
We acknowledge that the resulting (predictive) values,
however, may be overestimated. When applying E-screening
to the whole patient population, the ratio of eligible/ineli-
gible patients (prevalence) will decrease, subsequently also
lessening the positive predictive value (ie, relatively more
patients will be identified as false positively eligible).14 Ulti-
mately, this means that to identify 1 potential study partici-
pant the study coordinator may have to look through more
charts and spend more time than estimated by our validation
project. However, without electronic support, it would not at
all be possible for a single study coordinator to monitor the
entire inpatientpopulation ina tertiary center likeours,whichis 18 times larger than our chosen validation cohort. While the
database in our institution might be different from other
places,basedonourcurrentandpreviousexperiences,11,12we
believe that the principles of our findings are generalizable to
other hospital settings not only when targeting patients
admitted forCOPDexacerbationbuteaftermodificationealso
for identificationofvarious otherpopulationsof interest in the
field of respiratory medicine.
Conclusions
Our results showed that compared withmanual screening, E-
screening using a free-text search is an efficient, feasible,
and accurate method for identifying patients admitted for
COPD exacerbation. The presented E-screening method
reduces theworkload ofmanually identifying potential study
subjects by approximately three-quarters, thereby ensuring
efficient and accurate recruitment for the ongoing random-
ized controlled trial on COPD at our institution. Our results
are encouraging; this searchingmethodmay be used in other
institutional settings and be expanded into further fields of
clinical research and practice.
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